Загрузка...
Failed, Interrupted, or Inconclusive Trials on Neuroprotective and Neuroregenerative Treatment Strategies in Multiple Sclerosis: Update 2015–2020
In the recent past, a plethora of drugs have been approved for the treatment of multiple sclerosis (MS). These therapeutics are mainly confined to immunomodulatory or immunosuppressive strategies but do not sufficiently address remyelination and neuroprotection. However, several neuroregenerative ag...
Сохранить в:
| Опубликовано в: : | Drugs |
|---|---|
| Главные авторы: | , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Springer International Publishing
2021
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8217012/ https://ncbi.nlm.nih.gov/pubmed/34086251 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40265-021-01526-w |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|